Southampton is taking part in a world-first trial. SOUTHAMPTON is spearheading a world-first trial to identify the most effective booster vaccines in the battle against Covid-19. A new government-funded initiative will determine the immune responses triggered by each of the seven vaccines developed in a bid to defeat the killer virus. The trial will be led by University Hospital Southampton NHS Foundation Trust. A trust spokesperson said: Volunteers from Southampton, Portsmouth and Bournemouth will soon be able to receive a third ‘booster’ vaccine through a new clinical trial launching this week. The study, backed by £19.3m of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research Hub (Portsmouth Hospitals).
Southampton is taking part in a world-first trial. HAMPSHIRE is spearheading a world-first trial to identify the most effective booster vaccines in the battle against Covid-19. A new government-funded initiative will determine the immune responses triggered by each of the seven vaccines developed in a bid to defeat the killer virus. The trial will be led by University Hospital Southampton NHS Foundation Trust. A trust spokesperson said: Volunteers from Southampton, Portsmouth and Bournemouth will soon be able to receive a third ‘booster’ vaccine through a new clinical trial launching this week. The study, backed by £19.3m of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research Hub (Portsmouth Hospitals).
Southampton in world-first trial to find most effective Covid booster dailyecho.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyecho.co.uk Daily Mail and Mail on Sunday newspapers.
Don t show me this message again✕
The study will look at whether or not maternal antibodies are transferred to infants (POOL/AFP via Getty Images)
The first coronavirusvaccine study for women who are pregnant has been launched across a number of sites in the UK.
The study will look to understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech Covid-19 jab in women who are both pregnant and healthy.
Recruitment for the approximately 235 UK participants will begin this week, with the study taking place across eleven sites. These will include locations in Newcastle, Leeds, London, Oxford, Gillingham, Edinburgh and Southampton.